FundingWatcher
Home / Startups / Top biotech startups / Biotech startups that raised Series D or later / Biotech startups that raised Series D or later in California, United States

Biotech startups that raised Series D or later in California, United States

Updated 16 Nov 2026

Reset
Biotech startups that raised Series D or later in California, United States
One-time CSV
  • 111 funded companies, 102 with a website
  • Last round, amount, date, total raised and investors
  • CRM-ready CSV, 18 columns
  • Download right after payment
With founder contacts
Compiled to order
  • The full startup CSV, plus founders and executives
  • Up to 2 founders or CEOs per company, compiled to order
  • Name, job title and LinkedIn URL where found
  • Verified direct email per person
  • Startup CSV at once, contacts CSV by mail within 24 hours
Download right after paymentFree 10-row sampleSecure checkout by Stripe

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

startups-biotech--series-d-plus~california-united-states.csv111 rows × 18 columns
CompanyCityLast roundAmountDate
Circle PharmaSouth San FranciscoSeries E$92.5M2026-09-16
CraifIrvineSeries D$24.4M2026-08-18
Lycia TherapeuticsSouth San FranciscoSeries D$75.0M2026-06-25
Element BiosciencesSan DiegoSeries E$277.0M2026-06-09
Numerion LabsSan FranciscoSeries D$19.8M2026-03-19
Angitia BiopharmaceuticalsWestlake VillageSeries D$130.0M2026-02-05
Arthrosi TherapeuticsSan DiegoSeries E$153.0M2025-06-23
Clear LabsSan CarlosSeries D$30.0M2025-01-13

8 rows of the CSV in 5 of its 18 columns.

111
Startups
$20.7B
Total raised
10
Funded in the last 12 months
$1.3B
Raised in the last 12 months

Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.

Newest rounds

16 of 111
16 rows
Company What they do Sector City Last round Amount Date Total raised Investors Employees Founded
Circle Pharma Circle Pharma develops bioavailable macrocyclic peptide therapeutics that target protein-protein interactions. Biotech South San Francisco Series E $92.5M 2026-09-16 $300.0M Mission BioCapital, Pfizer, The Column Group +1 11 to 50 2012
Craif Craif develops a cancer diagnosis algorithm using microRNA data and machine learning. Artificial intelligence Irvine Series D $24.4M 2026-08-18 $68.7M Global Brain Corporation, VentureOut, ANRI +1 51 to 100 2018
Lycia Therapeutics Lycia Therapeutics develops technology using lysosome-targeting chimeras to degrade disease-causing proteins. Biotech South San Francisco Series D $75.0M 2026-06-25 $301.6M Franklin Templeton, Alexandria Venture Investments, Invus +1 11 to 50 2019
Element Biosciences Unicorn Element Biosciences develops genomic sequencing and multiomics technologies for drug discovery and diagnostic applications. Biotech San Diego Series E $277.0M 2026-06-09 $678.0M RA Capital Management, Fidelity, Wellington Management +2 251 to 500 2017
Numerion Labs Numerion Labs develops artificial intelligence systems for drug discovery using deep learning algorithms. Artificial intelligence San Francisco Series D $19.8M 2026-03-19 $241.4M Y Combinator, Khosla Ventures, Creative Destruction Lab +1 11 to 50 2012
Angitia Biopharmaceuticals Angitia Biopharmaceuticals develops biologic therapies for musculoskeletal diseases. Biotech Westlake Village Series D $130.0M 2026-02-05 $406.0M Legend Capital, OrbiMed, Oriza Holdings +1 51 to 100 2018
Arthrosi Therapeutics Arthrosi Therapeutics develops pharmaceutical treatments through clinical research and drug development programs. Biotech San Diego Series E $153.0M 2025-06-23 $277.4M Viva BioInnovator, Xiamen Changrong Investment Management, Viva Ventures Biotech Fund 11 to 50 2018
Clear Labs Clear Labs is a biotechnology firm that uses a genomics system to simplify diagnostics. Artificial intelligence San Carlos Series D $30.0M 2025-01-13 $156.5M Plug and Play, Alumni Ventures, Khosla Ventures +1 51 to 100 2014
Moximed Moximed develops therapies for patients with knee osteoarthritis. Biotech Hayward Series D $61.0M 2024-08-13 $244.2M New Enterprise Associates, Vertex Ventures, Cormorant Asset Management +1 11 to 50 2006
Truvian Sciences Truvian Sciences develops an automated benchtop system for lab-accurate blood testing. Biotech San Diego Series D $74.0M 2024-07-17 $208.1M General Catalyst, GreatPoint Ventures, Tao Capital Partners +2 101 to 250 2015
BillionToOne Unicorn BillionToOne offers genetic testing that detects disease through precision diagnostics. Biotech Menlo Park Series D $130.0M 2024-06-21 $425.9M Y Combinator, 500 Global, UpHonest Capital +1 501 to 1,000 2016
Perfect Day Unicorn Perfect Day produces dairy proteins that are nutritionally identical to proteins from cow's milk. Biotech Berkeley Series E $90.0M 2024-01-05 $801.5M SOSV, K5 Global, Temasek +2 101 to 250 2014
DNAnexus DNAnexus provides a cloud platform and network for scientific collaboration and research. Biotech Mountain View Series H $200.0M 2022-03-08 $472.6M Google Ventures, First Round Capital, Microsoft 101 to 250 2009
Synthego Synthego provides genome engineering services and CRISPR tools for life science research. Artificial intelligence Redwood City Series E $200.0M 2022-02-17 $459.7M Intel Capital, Founders Fund, Menlo Ventures +2 101 to 250 2012
Zymergen Zymergen is a biotechnology company that applies machine learning, big data and artificial intelligence. Artificial intelligence Emeryville Series D $300.0M 2020-09-08 $974.1M Goldman Sachs, DCVC, SoftBank +2 501 to 1,000 2013
Siperian Siperian provides model-driven software that delivers mobile management solutions for businesses. Biotech Foster City Series E $25.0M 2008-01-22 $50.2M Blumberg Capital, Brightspark Ventures, Investor Growth Capital Limited +2 1,001 to 5,000 2000

Table 1. Biotech startups that raised Series D or later in California, United States: the 16 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 111.

Largest rounds

Last 12 months
# Company What they do Sector City Last round Amount Date Total raised Investors Employees Founded
1 Element Biosciences Unicorn Element Biosciences develops genomic sequencing and multiomics technologies for drug discovery and diagnostic applications. Biotech San Diego Series E $277.0M 2026-06-09 $678.0M RA Capital Management, Fidelity, Wellington Management +2 251 to 500 2017
2 Angitia Biopharmaceuticals Angitia Biopharmaceuticals develops biologic therapies for musculoskeletal diseases. Biotech Westlake Village Series D $130.0M 2026-02-05 $406.0M Legend Capital, OrbiMed, Oriza Holdings +1 51 to 100 2018
3 Circle Pharma Circle Pharma develops bioavailable macrocyclic peptide therapeutics that target protein-protein interactions. Biotech South San Francisco Series E $92.5M 2026-09-16 $300.0M Mission BioCapital, Pfizer, The Column Group +1 11 to 50 2012
4 Lycia Therapeutics Lycia Therapeutics develops technology using lysosome-targeting chimeras to degrade disease-causing proteins. Biotech South San Francisco Series D $75.0M 2026-06-25 $301.6M Franklin Templeton, Alexandria Venture Investments, Invus +1 11 to 50 2019
5 Craif Craif develops a cancer diagnosis algorithm using microRNA data and machine learning. Artificial intelligence Irvine Series D $24.4M 2026-08-18 $68.7M Global Brain Corporation, VentureOut, ANRI +1 51 to 100 2018
6 Numerion Labs Numerion Labs develops artificial intelligence systems for drug discovery using deep learning algorithms. Artificial intelligence San Francisco Series D $19.8M 2026-03-19 $241.4M Y Combinator, Khosla Ventures, Creative Destruction Lab +1 11 to 50 2012

Table 2. Biotech startups that raised Series D or later in California, United States: the 6 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most active investors

By companies backed
#InvestorTypeLocation CompaniesShare Funded, 12 monthsLatest
1 Y Combinator Startup accelerator Mountain View, United States 3 3% 1 Numerion Labs
2 Wellington Management Private equity firm Boston, United States 2 2% 1 Element Biosciences
3 RA Capital Management Startup incubator Boston, United States 2 2% 1 Element Biosciences
4 Khosla Ventures Venture capital firm Menlo Park, United States 2 2% 1 Numerion Labs
5 OrbiMed Private equity firm New York, United States 2 2% 1 Angitia Biopharmaceuticals
6 Menlo Ventures Venture capital firm Menlo Park, United States 2 2%
7 Baillie Gifford Private equity firm Edinburgh, United Kingdom 2 2%
8 Intel Capital Corporate venture arm Santa Clara, United States 2 2%
9 Qualcomm Ventures Corporate venture arm San Diego, United States 2 2%
10 Pfizer Corporate venture arm New York, United States 1 1% 1 Circle Pharma
11 Mission BioCapital Venture capital firm Cambridge, United States 1 1% 1 Circle Pharma
12 Nextech Invest Venture capital firm Zürich, Switzerland 1 1% 1 Circle Pharma
13 The Column Group Venture capital firm San Francisco, United States 1 1% 1 Circle Pharma
14 VentureOut Startup accelerator New York, United States 1 1% 1 Craif
15 Global Brain Corporation Venture capital firm Tokyo, Japan 1 1% 1 Craif

Table 3. Biotech startups that raised Series D or later in California, United States: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Sectors

SectorsCompaniesShareTotal raised
Health care 96 86% $16.8B
Software 11 10% $3.0B
Artificial intelligence 7 6% $2.3B
Hardware 5 5% $1.3B
Energy 2 2% $228.7M
Cybersecurity 1 1% $188.7M
Fintech 1 1% $72.6M

Table 4. Biotech startups that raised Series D or later in California, United States by sector. Source: FundingWatcher. Data as of 16 November 2026.

Funding stage

Funding stageCompaniesShareMedian last round
Series D+ 111 100% $43.7M

Table 5. Biotech startups that raised Series D or later in California, United States by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Cities

CitiesCompaniesShare
San Diego 18 16%
South San Francisco 11 10%
Redwood City 9 8%
San Francisco 7 6%
Santa Clara 5 5%
Mountain View 5 5%
Hayward 4 4%
Berkeley 4 4%
Menlo Park 3 3%
La Jolla 3 3%
Fremont 3 3%
Sunnyvale 3 3%

Table 6. Biotech startups that raised Series D or later in California, United States by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.

Rounds by month

Rounds by monthCompaniesShareRaised
October 2026 1 10% $50.7M
September 2026 2 20% $367.5M
August 2026 1 10% $24.4M
June 2026 2 20% $352.0M
May 2026 1 10% $52.0M
March 2026 1 10% $19.8M
February 2026 1 10% $130.0M
January 2026 1 10% $257.0M

Table 7. Biotech startups that raised Series D or later in California, United States: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most recent round by year

Most recent round by yearCompaniesShareRaised
2026 10 9% $1.3B
2025 8 7% $1.1B
2024 7 6% $487.3M
2023 5 5% $327.0M
2022 3 3% $560.0M
2021 8 7% $849.0M

Table 8. Biotech startups that raised Series D or later in California, United States by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Founding year

Founding yearCompaniesShare
2020 to 2022 1 1%
2015 to 2019 20 18%
2010 to 2014 17 15%
Before 2010 72 65%

Table 9. Biotech startups that raised Series D or later in California, United States by founding year. Source: FundingWatcher. Data as of 16 November 2026.

Team size

Team sizeCompaniesShare
1 to 10 10 9%
11 to 50 35 32%
51 to 100 35 32%
101 to 250 12 11%
251 to 500 7 6%
501 to 1,000 5 5%
1,001 to 5,000 3 3%
5,001 to 10,000 1 1%
10,001 or more 1 1%

Table 10. Biotech startups that raised Series D or later in California, United States by headcount. Source: FundingWatcher. Data as of 16 November 2026.

Method

Sources, fields and exclusions of both files: Method.

Questions

How many biotech startups in California, United States whose last round is Series D or later are on the list?
111, in the file dated 16 November 2026. 10 of them closed their most recent round in the last 12 months.
What does the CSV contain?
One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
How much does the list cost?
$29 one-time for all 111 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
What arrives after payment?
At once: the CSV download link, on the page after payment and by mail.
Can I see rows before buying?
The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
How current is the data?
The file is dated 16 November 2026. The download link serves the current file each time it is opened.

Biotech startups that raised Series D or later in California, United States: 111 rows, CSV, $29 one-time.

At once: the CSV download link, on the page after payment and by mail.

Columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.

With founder contacts: $199 one-time. List CSV right after payment; up to 2 verified founder or CEO emails per company compiled to order within 24 hours.

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

Biotech at other stages in California

Other sectors that raised Series D or later in California

Cite: FundingWatcher, 111 biotech companies in California, United States whose most recent round is Series D or later, 16 November 2026. https://fundingwatcher.com/startups/biotech/series-d-plus/california-united-states/